Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also... see more

Recent & Breaking News (NYSE:GSK)

FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer

PR Newswire April 22, 2021

Advil to Reduce Plastic in Over 80 Million Bottles by 20% with New Sustainable Plastic Technology

PR Newswire April 19, 2021

GSK Global Head of Vaccine Research and Development Joins Viome To Tackle Chronic Diseases

PR Newswire April 15, 2021

Flonase teams up with Major League Baseball and World Series champion Cody Bellinger to change the game on allergy season

PR Newswire April 1, 2021

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19

GlobeNewswire March 29, 2021

GSK and Vir Biotechnology Announce Submission of Emergency Use Authorization Request to FDA for VIR-7831 for the Early Treatment of COVID-19

GlobeNewswire March 26, 2021

Vir Biotechnology and GSK Provide Update on NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

GlobeNewswire March 3, 2021

TUMS Expands Portfolio to Meet Consumer Demands for Naturally-Sourced Products

PR Newswire February 16, 2021

GSK and CureVac to Develop Next Generation MRNA COVID-19 Vaccines

Accesswire February 3, 2021

TUMS® Kicks Off $55,000 #TUMSBingoSweepstakes for the BIG GAME

PR Newswire February 1, 2021

Lilly, Vir Biotechnology and GSK Announce First Patient Dosed in Expanded BLAZE-4 Trial Evaluating Bamlanivimab (LY-CoV555) with VIR-7831 (GSK4182136) for COVID-19

GlobeNewswire January 27, 2021

Vir Biotechnology and GSK Announce NHS-Supported AGILE Study to Evaluate VIR-7832 in the Early Treatment of COVID-19

GlobeNewswire January 12, 2021

Eligo inks deal with GSK potentially worth up to $224M

PR Newswire January 11, 2021

Vir Biotechnology and GSK Announce Start of NIH-Sponsored ACTIV-3 Trial Evaluating VIR-7831 in Hospitalized Adults with COVID-19

GlobeNewswire December 17, 2020

FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US

PR Newswire December 17, 2020

GSK Consumer Healthcare Partners with Direct Relief to Donate $1 Million to Support Frontline Healthcare Workers

PR Newswire December 1, 2020

ViiV Healthcare and Shutterstock Studios unite to tackle outdated perceptions of HIV with 'HIV in View'--a first-of-its-kind online HIV photography gallery

PR Newswire December 1, 2020

Robitussin Launches Their First-Ever Drug-Free Products for Cough Relief with a Cheerful Collaboration

PR Newswire October 28, 2020

ViiV Healthcare presents a new podcast about the Power of Being Seen

PR Newswire October 1, 2020

FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)

Business Wire September 25, 2020